Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases

References

• Forum of International Respiratory Societies. The Global Impact of Respiratory Disease – Second Edition. Sheffield, European Respiratory Society. 2017: Available from: https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf. (Last visit: 2021 Apr 18th).
   Google Scholar
• Soriano JB. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2017;8(6):585–596.
   Google Scholar
• Chronic obstructive pulmonary disease (COPD). Australian Institute of Health and Welfare (AIHW) 2020. Cat. no: ACM 35 [Cited Nov 2020]. Available from: https://www.aihw.gov.au›reports›copd›contents›copd. ( Last visit: February 28th 2021).
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Australian burden of disease study: impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2011. [Cited 2021 Apr 18]. Available from: https://www.aihw.gov.au/reports/burden-of-disease/australian-bod-study-2011-indigenous-australians/contents/summary.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander Health Performance Framework 2017 report: Northern Territory. [Cited 2021 Apr 18]. Available from: https://www.aihw.gov.au/getmedia/0e60dc3c-a582-4b7f-a4d1-1e623a91745e/aihw-ihw-186-2017-hpf-nt.pdf.aspx?inline=true
   Google Scholar
• Population - Australian Bureau of Statistics. Canberra March 2020. [cited 2021 Feb). Available from: https://www.abs.gov.au›AUSSTATS.
   Google Scholar
• Australian Bureau of Statistics. Estimates of aboriginal and torres strait islander Australians, June 2016. Canberra: ABS; 2016.
   Google Scholar
• Australian Bureau of Statistics. Australian statistical geography standard (ASGS): Volume 5—remoteness structure. Canberra: Australian Bureau of Statistics; 2011 July. ABS cat. no. 1270.0.55.005
   Google Scholar
• Kruavit A, Fox M, Pearson R, et al. Chronic respiratory disease in the regional and remote population of the northern territory top end: a perspective from the specialist respiratory outreach service. Aust J Rural Health. 2017;25(5):275–284.
   PubMed Web of Science ®Google Scholar
• Blackall SR, Hong JB, King P, et al. Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand respirology. 2018;23(8):743–749.
   Google Scholar
• Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians – a comparative study. Int Med J. 2020;50(12):1505–1513.
   Google Scholar
• Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease in aboriginal patients of The Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis. 2019;14:2205–2217.
   PubMed Web of Science ®Google Scholar
• Johnson JD, Theurer WH. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician. 2014;89(5):359–366.
   PubMed Web of Science ®Google Scholar
• Thompson BR, Stanojevic S, Abramson MJ, et al. On behalf of the ANZSRS reference ranges working party. The all‐age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology. 2011;16(6):912–917.
   PubMed Web of Science ®Google Scholar
• Hall GL, Thompson BR, Stanojevic S, et al. The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology 2012;17(7):1150–1151.
   PubMed Web of Science ®Google Scholar
• Blake TL, Chang AB, Petsky HL, et al. Spirometry reference values in Indigenous Australians: a systematic review. Med J Aust. 2016;205(1):35–40.
   PubMed Web of Science ®Google Scholar
• Verheijden MW, Ton A, James AL, et al. Respiratory morbidity and lung function in two Aboriginal communities in Western Australia. Respirology. 2002;7(3):247–253.
   PubMed Web of Science ®Google Scholar
• Bremner PR, De Klerk NH, Ryan GF, et al. Respiratory symptoms and lung function in aborigines from tropical Western Australia. Am J Respir Crit Care Med. 1998;158(6):1724–1729.
   PubMed Web of Science ®Google Scholar
• Thompson JE, Sleigh AC, Passey ME, et al. Ventilatory standards for clinically well aboriginal adults. Med J Aust. 1992;156(8):566–569.
   PubMed Web of Science ®Google Scholar
• Musk A, James AL, Palmer LJ, et al. Respiratory infections and lung function in an Australian Aboriginal community. Respirology. 2008;13(2):257–262.
   PubMed Web of Science ®Google Scholar
• Veale A, Peat J, Salome C, et al. ‘Normal lung function in rural Australian Aborigines. Aust N Z J Med. 1997;27(5):543–549.
   PubMedGoogle Scholar
• Schubert J, Kruavit A, Mehra S, et al. Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory. Intern Med J. 2019;49(2):217–224.
   PubMed Web of Science ®Google Scholar
• Cooksley NA, Atkinson D, Marks GB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross‐sectional BOLD study. Respirology 2015;20(5):766–774.
   PubMed Web of Science ®Google Scholar
• Hall GL, Pearson G. Reduced forced vital capacity in Aboriginal Australians: biology or missing evidence? Respirology 2015;20(5):693–694.
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Howarth T, White E, et al. Lung function parameters among “apparently healthy” Australian Aboriginal Adults: an Australian Caucasian and Global Lung Initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med. 2020;23:1–11.
   Google Scholar
• Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(3). Art. No.: CD010115. DOI:10.1002/14651858.CD010115.pub2.
   Web of Science ®Google Scholar
• Heraganahally SS, Ghataura AS, Er XY, et al. Excessive dynamic airway collapse: a COPD/Asthma mimic or a treatment emergent consequence of inhaled corticosteroid therapy - case series and brief literature review. Clin Pulm Med. 2020;27(6):175–182.
   Google Scholar
• Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis. 1987;70(1):1–7.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. “ATS/ERS task force: standardisation of lung function testing”. Eur Respir J. 2005;26(2):319–338.
   PubMed Web of Science ®Google Scholar
• ndd Medical Technologies, 2017. EasyOne Pro®. Available from: https://www.ndd.ch/en/product/easyone-pro.html. (Last visit: 2021 Jan 10th).
   Google Scholar
• Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. MJA. 2013;198(3):144–148.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (Updated 2007). (cited 2017). Available from: http://www.goldcopd.org. ( Last visit: April 18th 2021).
   Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Brazzale D, Hall G, Swanney MP. Reference values for spirometry and their use in test interpretation: a position statement from the Australian and New Zealand society of respiratory science. Respirology. 2016;21(7):1201–1209.
   PubMed Web of Science ®Google Scholar
• StataCorp LLC. STATA IC 15.1. Texas, USA: StataCorp LLC; 2016.
   Google Scholar
• Kaf O, Revell A, Maguire GP, et al. Lung health care for aboriginal and torres strait islander Queenslanders: breathing easy is not so easy. Aust Health Rev. 2011;35(4):512–519.
   PubMed Web of Science ®Google Scholar
• Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;28(10):1465–1475.
   Web of Science ®Google Scholar
• Novosad SA, Barker AF. Chronic obstructive pulmonary disease and bronchiectasis. Curr Opin Pulm Med. 2013;19(2):133–139.
   PubMed Web of Science ®Google Scholar
• Mehra S, Chang AB, Lam CK, et al. Bronchiectasis among Australian aboriginal and non-aboriginal patients in the regional and remote population of the Northern Territory of Australia. Rural Remote Health. 2021;21(2):6390.
   PubMed Web of Science ®Google Scholar
• Ospina MB, Voaklander DC, Stickland MK, et al. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J. 2012;19(6):355–360.
   PubMed Web of Science ®Google Scholar
• Arram EO, Elrakhawy MM. Bronchiectasis in COPD patients. Egypt J Chest Dis Tuberc. 2012;61(4):307–312.
   Google Scholar
• Guan WJ, Gao YH, Xu G, et al. Characterization of lung function impairment in adults with bronchiectasis. PLoS One. 2014;9(11):e113373. 18.
   PubMed Web of Science ®Google Scholar
• Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000;55(3):198–204.
   PubMed Web of Science ®Google Scholar
• Radovanovic D, Santus P, Blasi F, et al. A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018;145:120–129.
   PubMed Web of Science ®Google Scholar
• Melo LC, Silva MA, Calles AC. Obesity and lung function: a systematic review. Einstein (Sao Paulo). 2014;12(1):120–125.
   PubMedGoogle Scholar
• Ben Saad H, Tfifha M, Harrabi I, et al. Factors influencing pulmonary function in Tunisian women aged 45 years and more. Rev Mal Respir. 2006;23(4 Pt 1):324–338.
   PubMed Web of Science ®Google Scholar
• Ben Saad H, Rouatbi S, Raoudha S, et al. Vital capacity and peak expiratory flow rates in a North-African population aged 60 years and over: influence of anthropometric data and parity. Rev Mal Respir. 2003;20(4):521–530.
   PubMed Web of Science ®Google Scholar
• Ghobain A. The effect of obesity on spirometry tests among healthy non-smoking adults BMC Pulmonary Medicine. 2012; 12:10. [cited 2021 Feb]. Available from: http://www.biomedcentral.com/1471-2466/12/10.
   Google Scholar
• Bottai M, Pistelli F, Di Pede F, et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J. 2002;20(3):665–673.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun X, Hsia TC, et al. The effects of body mass index on spirometry tests among adults in Xi’an, China. Medicine (Baltimore). 2017;96(15):e6596.
   PubMed Web of Science ®Google Scholar
• Howarth T, Saad HB, Perez AJ, et al. Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults. PLoS One. 2021;16(4):e0248900.
   PubMed Web of Science ®Google Scholar
• Athanazio R. Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (San Paulo). 2012;67(11):1335–1343.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Madabhavi I, Niranjan N, et al. Auscultation of the respiratory system. Ann Thorac Med. 2015;10(3):158–168.
   PubMed Web of Science ®Google Scholar
• Paraskeva MA, Borg BM, Naughton MT. Spirometry. Aust Fam Physician. 2011;40(4):216–219.
   PubMedGoogle Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64(8):728–735.
   PubMed Web of Science ®Google Scholar